Matches in Wikidata for { <http://www.wikidata.org/entity/Q93363763> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q93363763 description "article scientifique publié en 2018" @default.
- Q93363763 description "artículu científicu espublizáu en payares de 2018" @default.
- Q93363763 description "scientific article published on 22 November 2018" @default.
- Q93363763 description "wetenschappelijk artikel" @default.
- Q93363763 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q93363763 name "Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies" @default.
- Q93363763 name "Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies" @default.
- Q93363763 type Item @default.
- Q93363763 label "Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies" @default.
- Q93363763 label "Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies" @default.
- Q93363763 prefLabel "Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies" @default.
- Q93363763 prefLabel "Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies" @default.
- Q93363763 P1433 Q93363763-21EFDF8A-8BCA-4284-BB06-7DD4BFC21F25 @default.
- Q93363763 P1476 Q93363763-990F780E-67BC-4C33-B271-0050797151CC @default.
- Q93363763 P2093 Q93363763-02EAAA6C-5179-4477-9636-C53FB5E76D16 @default.
- Q93363763 P2093 Q93363763-057B4553-C9AA-4B94-98C8-A9ACA83F78DF @default.
- Q93363763 P2093 Q93363763-0E1D9A25-2178-4BC8-843E-44D5D3D50022 @default.
- Q93363763 P2093 Q93363763-19A7D6FB-4B6D-4ED7-BC97-E5B7C5D98535 @default.
- Q93363763 P2093 Q93363763-1F267FC0-B29B-4746-A365-20FAE9B664BF @default.
- Q93363763 P2093 Q93363763-2F7468C4-0954-4E3A-89F8-51502A83F1C5 @default.
- Q93363763 P2093 Q93363763-33CEF979-ED10-4DF7-B3CD-EA0946FC822F @default.
- Q93363763 P2093 Q93363763-4A43DBE9-5FC6-49AF-AC69-DA3D50832680 @default.
- Q93363763 P2093 Q93363763-5E75CB41-15A2-41FB-8963-2C9F559C5CEF @default.
- Q93363763 P2093 Q93363763-7E78BBD7-5B0D-4E4E-BB68-E92C972661BB @default.
- Q93363763 P2093 Q93363763-B4D59B1F-3C3F-49B5-AFB7-AF636A3CBF87 @default.
- Q93363763 P2093 Q93363763-E7D022A3-687E-465D-85C3-4986E2F344FD @default.
- Q93363763 P2093 Q93363763-F20CF453-85A3-44CD-A797-EA3E0780DE8E @default.
- Q93363763 P304 Q93363763-F1136111-0771-447C-9861-77F79A49F6FF @default.
- Q93363763 P31 Q93363763-1482EDBE-5EED-4AA1-8D17-35F6736722CF @default.
- Q93363763 P356 Q93363763-7FC6188D-CF0E-4BD0-AD80-779C2B8EB4C2 @default.
- Q93363763 P433 Q93363763-C76D6F6D-1942-4B8E-BD99-E301F830E4DF @default.
- Q93363763 P478 Q93363763-DACC4473-24A9-495E-A245-2EC1DEC4B83C @default.
- Q93363763 P50 Q93363763-125C6054-3CA5-41EC-AC55-9DA676BD0E33 @default.
- Q93363763 P50 Q93363763-D2680CBC-7525-4404-B46A-48031EFFC4B5 @default.
- Q93363763 P50 Q93363763-EEC99266-6A26-487E-B2BA-E8D8A69F1520 @default.
- Q93363763 P577 Q93363763-BD8CE391-22B7-4708-B88C-657F90281C1F @default.
- Q93363763 P698 Q93363763-D779EC38-FC06-4523-92F5-73C52DE1DA3C @default.
- Q93363763 P921 Q93363763-4C449B43-1C7C-4CCF-A8FB-F7B22936C318 @default.
- Q93363763 P356 BJH.15685 @default.
- Q93363763 P698 30467838 @default.
- Q93363763 P1433 Q4970200 @default.
- Q93363763 P1476 "Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies" @default.
- Q93363763 P2093 "Andrew Clark" @default.
- Q93363763 P2093 "Andy J Peniket" @default.
- Q93363763 P2093 "Anna Schuh" @default.
- Q93363763 P2093 "Anne Parker" @default.
- Q93363763 P2093 "Charles Craddock" @default.
- Q93363763 P2093 "Chris Hatton" @default.
- Q93363763 P2093 "Francesca M Jones" @default.
- Q93363763 P2093 "Janice Ward" @default.
- Q93363763 P2093 "Katharine Hanlon" @default.
- Q93363763 P2093 "Patrick Medd" @default.
- Q93363763 P2093 "Ram Malladi" @default.
- Q93363763 P2093 "Robert Danby" @default.
- Q93363763 P2093 "Sridar Chaganti" @default.
- Q93363763 P304 "547-557" @default.
- Q93363763 P31 Q13442814 @default.
- Q93363763 P356 "10.1111/BJH.15685" @default.
- Q93363763 P433 "4" @default.
- Q93363763 P478 "184" @default.
- Q93363763 P50 Q55172665 @default.
- Q93363763 P50 Q56383263 @default.
- Q93363763 P50 Q60430663 @default.
- Q93363763 P577 "2018-11-22T00:00:00Z" @default.
- Q93363763 P698 "30467838" @default.
- Q93363763 P921 Q65592366 @default.